New medicine for opening blocked arteries after severe stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a new medicine called LT3001 for people who had a recent severe stroke caused by a blocked artery in the brain. It aims to reopen the blocked vessel and improve recovery, and is given within 24 hours of symptom onset without standard clot-busting treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 88 years old.
- You have had an acute ischemic stroke (a blocked artery in your brain) with symptoms starting within the last 24 hours.
- You have not yet received standard clot-busting medication (IV thrombolysis) or had a mechanical clot removal procedure.
- Your stroke severity is moderate, as measured by a standard score (NIHSS between 6 and 23).
- You are able to undergo and are eligible for a brain scan (CT or MRI) to confirm the blockage.
- You do not have certain conditions that increase bleeding risk, such as recent bleeding, low platelets, or uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injectable drug called LT3001 that may help dissolve blood clots in the brain after a stroke. It is given within 24 hours of stroke onset, and the goal is to reduce disability and improve recovery.
This Phase 2 study tests LT3001 to improve recovery after an acute ischemic stroke (a stroke caused by blocked blood flow). It is designed for people who can be treated within 24 hours of symptom onset and who meet specific safety and health requirements.
This study tests a rescue treatment for people having a major stroke caused by a blocked artery in the brain that also has severe narrowing. If doctors can't fully open the artery with standard clot removal, this study looks at whether additional treatments can help.
This trial tests a new drug, J147, for people who recently had a stroke caused by a blocked artery and have already had a procedure to reopen that artery. It aims to see if the drug can improve recovery.
This trial tests a new drug called BB-031 for people who have had a stroke caused by a blocked blood vessel in the brain. The drug may help restore blood flow and reduce damage if given within 24 hours of symptoms starting.
This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.